Disparities in the monitoring and complication screening of people with Type 2 diabetes

Disparities in the monitoring and complication screening of people with Type 2 diabetes

Bibliographic Details
Main Authors:	Hinton, W, McGovern, A, Arrowsmith, B, Munro, N, Whyte, M, de Lusignan, S
Format:	Conference item
Language:	English
Published:	Wiley 2017

Similar Items

Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK
by: McGovern, A, et al.
Published: (2016)

Ethnic and socioeconomic disparities in type 2 diabetes care: A trend analysis
by: Hinton, W, et al.
Published: (2017)

Does the presence of NAFLD influence prescribing behaviour in Type 2 diabetes?
by: Whyte, MB, et al.
Published: (2017)

Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis
by: Whyte, M, et al.
Published: (2019)

Disparities in prescribing of sodium-glucose co-transporter-2 (SGLT2) inhibitors and DPP-4 inhibitors in people with Type 2 diabetes and chronic kidney disease (CKD)
by: Shah, S, et al.
Published: (2018)

A class comparison of medication persistence in people with type 2 diabetes: A retrospective observational study
by: McGovern, A, et al.
Published: (2018)

Ethnic disparities in medication persistence in Type 2 diabetes: non-whites have reduced persistence
by: McGovern, AP, et al.
Published: (2016)

What predicts early glycaemic control in people with type 2 diabetes?
by: McGovern, AP, et al.
Published: (2017)

Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
by: Martin B Whyte, et al.
Published: (2019-10-01)

Comparison of medication adherence and persistence in type 2 diabetes: A systematic review and meta‐analysis
by: McGovern, A, et al.
Published: (2017)

Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol
by: McGovern, A, et al.
Published: (2016)

Association between diabetes, level of glycemic control, and eye infection: a cohort study
by: Ansari, A, et al.
Published: (2016)

Real world evidence for legacy effect of early glycaemic control in type 2 diabetes on risk of macrovascular disease
by: Whyte, M, et al.
Published: (2017)

Is diabetes really a risk factor for acute eye infection?
by: Ansari, AS, et al.
Published: (2017)

The distinct epidemiology of 'Type 3c' diabetes should prompt consideration of chronic pancreatic disease as the possible cause of a patient's diabetes
by: Woodmansey, C, et al.
Published: (2017)

Glycaemic trajectories in type 2 diabetes and risk of cardiovascular disease: Exploring the link
by: Whyte, MB, et al.
Published: (2019)

The association between diabetes, level of glycaemic control and eye infection: cohort database study
by: Ansari, A, et al.
Published: (2017)

Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: a primary care cohort study
by: Whyte, MB, et al.
Published: (2022)

Glycemic control is an important modifiable risk factor for uveitis in patients with diabetes: A retrospective cohort study establishing clinical risk and ophthalmic disease burden
by: Ansari, AS, et al.
Published: (2018)

Measuring quality of healthcare outcomes in type 2 diabetes from routine data: a seven-nation survey conducted by the IMIA Primary Health Care Working Group
by: Hinton, W, et al.
Published: (2017)

What are the HbA(1c) thresholds for initiating insulin therapy in people with type 2 diabetes in UK primary care?
by: Hinton, W, et al.
Published: (2016)

Differences in persistence by class of oral therapy for the treatment of type 2 diabetes
by: McGovern, AP, et al.
Published: (2016)

Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism
by: Hinton, W, et al.
Published: (2020)

A national audit of SGLT2 use in England
by: McGovern, A, et al.
Published: (2017)

Obstructive sleep apnoea in Type 2 diabetes mellitus: increased risk for overweight as well as obese people included in a national primary care database analysis
by: Feher, M, et al.
Published: (2019)

Incidence, demographics, and clinical characteristics of diabetes of the exocrine pancreas (type 3c): A retrospective cohort study
by: Woodmansey, C, et al.
Published: (2017)

Intensification to injectable therapy in type 2 diabetes: mixed methods study (protocol).
by: De Lusignan, S, et al.
Published: (2019)

Preconception folic acid uptake in women with diabetes of childbearing age: findings from the Royal College of General Practitioners Research Surveillance Centre
by: Coleman, M, et al.
Published: (2017)

Metformin is associated with reduced risk of venous thromboembolism in Type 2 diabetes: a national primary care database study
by: Hinton, W, et al.
Published: (2019)

Type 2 diabetes and asthma: systematic review of the bidirectional relationship
by: Rayner, L, et al.
Published: (2019)

GLP-1 RA treatment: a benefit-risk analysis from a retrospective cohort study
by: Konstantara, E, et al.
Published: (2018)

Association between glycaemic control and common infections in people with Type 2 diabetes: a cohort study
by: Hine, J, et al.
Published: (2016)

Does renal function or heart failure diagnosis affect primary care prescribing for sodium-Glucose co-transporter 2 inhibitors in type 2 diabetes?
by: Hinton, W, et al.
Published: (2020)

Sodium-glucose co-transporter-2 (SGLT2) inhibitors: comparing trial and real world use (study protocol)
by: McGovern, A, et al.
Published: (2017)

Sodium-glucose co-transporter 2 (SGLT2) inhibitor: comparing trial data and real-world use
by: McGovern, A, et al.
Published: (2017)

Insulin therapy in type 3c diabetes—more common in chronic rather than acute pancreatitis
by: Hinton, W, et al.
Published: (2018)

The impact of therapy on the risk of asthma in type 2 diabetes
by: Rayner, LH, et al.
Published: (2019)

Type 2 diabetes: a protective factor for COPD?
by: Rayner, L, et al.
Published: (2018)

Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort study
by: McGovern, AP, et al.
Published: (2013)

Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis
by: Hinton, W, et al.
Published: (2021)